Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
$0.67−0.10 (-12.58%)
Close on Nov 17, 2026Market cap $7.93MP/E –Yield –
Radiopharm Theranostics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2026 it was -$56.78M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$56.78M | – |
| FY2025 | Jun 30, 2025 | -$38.17M | – |
| FY2024 | Jun 30, 2024 | -$47.21M | – |
| FY2023 | Jun 30, 2023 | -$34.49M | – |
See a number that looks wrong?